Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic
Authors:
Open Access
- 1 April 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 4 (2) , ofx023
Abstract
Antibody and T-cell immunity to conserved influenza virus antigens can protect animals against infection with diverse influenza strains. Although immunity against conserved antigens occurs in humans, whether such responses provide cross-protection in humans and could be harnessed as the basis for universal influenza vaccines is controversial. The 2009 pandemic provided an opportunity to investigate whether pre-existing cross-reactive immunity affected susceptibility to infection. In 2009, we banked sera and peripheral blood mononuclear cells (PBMC) from blood donors, then monitored them for pandemic influenza infection (pH1N1) by polymerase chain reaction or seroconversion. Antibodies to hemagglutinin (HA), neuraminidase (NA), nucleoprotein (NP), matrix 2 (M2), and HA-pseudotypes were measured in sera. T-cell inteferon-γ enzyme-linked immunospot responses were measured in PBMC. There were 13 infections in 117 evaluable donors. Pre-existing T-cell reactivity to pH1N1 was substantial (of 153 donors tested, 146 had >100 spot-forming cells/106 cells). Antibodies reactive with pH1N1 were common: anti-NP (all donors) and anti-M2 (44% of donors). Pseudotype-neutralizing antibodies to H1 were detected, but not to highly conserved HA epitopes. Unexpectedly, donors with symptomatic pH1N1 infection had sharp rises in HA pseudotype-neutralizing antibodies, not only pH1N1 but also against multiple seasonal H1s. In addition, an exploratory study of a T-cell marker (response to NP418-426) identified probable infection missed by standard criteria. Although the number of infections was inadequate for conclusions about mechanisms of protection, this study documents the wide variety of pre-existing, cross-reactive, humoral and cellular immune responses to pandemic influenza virus antigens in humans. These responses can be compared with results of other studies and explored in universal influenza vaccine studies.Keywords
This publication has 38 references indexed in Scilit:
- Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity Antibodies in the Absence of Neutralizing AntibodiesThe Journal of Immunology, 2013
- Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humansNature Medicine, 2012
- Development and evaluation of an M2-293FT cell-based flow cytometric assay for quantification of antibody response to native form of matrix protein 2 of influenza A virusesJournal of Immunological Methods, 2011
- Contributions of Antinucleoprotein IgG to Heterosubtypic Immunity against Influenza VirusThe Journal of Immunology, 2011
- Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A virusesProceedings of the National Academy of Sciences, 2010
- Characterization of lentiviral pseudotypes with influenza H5N1 hemagglutinin and their performance in neutralization assaysJournal of Virological Methods, 2010
- H1N1: Can a Pandemic Cycle Be Broken?Science Translational Medicine, 2010
- Prior H1N1 Influenza Infection and Susceptibility of Cleveland Family Study Participants during the H2N2 Pandemic of 1957: An Experiment of NatureThe Journal of Infectious Diseases, 2006
- Human CD8+ and CD4+ T Lymphocyte Memory to Influenza A Viruses of Swine and Avian SpeciesThe Journal of Immunology, 1999
- Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 proteinVaccine, 1995